Japanese firms Mitsui & Rohto Pharma buy Singapore-based consumer healthcare brand for ¥88 B

Japan-based Mitsui & Co., has decided to acquire shares in Eu Yan Sang International (EYS) jointly with Rohto Pharma...

April 8, 2024 | Monday | News
Singapore approves new asthma indication for GSK's Trelegy Ellipta

GSK Singapore has announced that the Health Sciences Authority (HSA) has approved a new indication and a new strength fo...

April 5, 2024 | Friday | News
Japan's NS Pharma & UK-based MiNA Therapeutics lay focus on rare diseases of Central Nervous System

NS Pharma, Inc. has announced that its parent company, Nippon Shinyaku Co., headquartered in Kyoto, Japan, has ente...

April 4, 2024 | Thursday | News
CMS and Incyte collaborate to develop vitiligo drug Povorcitinib in China and Southeast Asia

China Medical System Holdings (CMS) and Incyte have entered into a collaboration and license agreement for the developme...

April 4, 2024 | Thursday | News
“Because of its specificity and selectivity, ADCs have the potential to reduce adverse side effects and improve patient survival”

How does Daiichi Sankyo leverage antibody-drug conjugates (ADCs) to execute precision therapeutics? Daiichi Sankyo has ...

April 1, 2024 | Monday | Opinion
Eisai to divest rights for Merislon and Myonal in Japan to Kaken Pharma for ¥ 3.8 B

Eisai Co. has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon ...

March 29, 2024 | Friday | News
Japanese pharma firms Eli Lilly, Nippon Shinyaku join hands to strengthen haematologic oncology field

Nippon Shinyaku and Eli Lilly Japan K.K have entered into an alliance agreement in Japan for pirtobrutinib, which ...

March 28, 2024 | Thursday | News
Novo Nordisk invests ¥4 B in China for sterile preparation expansion project

Danish pharma firm Novo Nordisk has announced that it would invest approximately 4 billion yuan (¥) in Tianjin for a...

March 22, 2024 | Friday | News
Singapore gives nod to China-based Everest Medicines' drug for nephropathy treatment

Everest Medicines, a China-based biopharmaceutical company focused on the discovery, development, manufacturing and comm...

March 20, 2024 | Wednesday | News
India's Sun Pharmaceuticals announces approval of Winlevi in Australia for acne treatment

India-based Sun Pharmaceutical Industries has announced that the Australian Therapeutic Goods Administration (TGA) has g...

March 20, 2024 | Wednesday | News
Zuellig Pharma to commercialise anti-fungal medication across key markets in Asia

Singapore-headquartered Zuellig Pharma, a leading healthcare solutions company in Asia, has expanded its commercialisati...

March 18, 2024 | Monday | News
Novartis expands its biopharmaceutical manufacturing site in Singapore

Novartis is investing $256 million to expand its biopharmaceutical manufacturing plant in Singapore. The extended s...

March 15, 2024 | Friday | Company results
CPHI Japan 2024 to see more than 20% year-on-year rise

CPHI Japan 2024, being held from 17 to19 April, will see a 20+% year-on-year rise, with a record attendance of an expect...

March 12, 2024 | Tuesday | News
Sulzer opens new cutting-edge Innovation Technology Hub in Singapore

Sulzer offcialy opened its new Innovation Technology Hub (InTecH) in Singapore’s Jurong Innovati...

March 11, 2024 | Monday | News
Luye Pharma launches Zepzelca drug in Hong Kong and Macao for treatment of Small Cell Lung Cancer

Luye Pharma has launched its innovative drug Zepzelca (lurbinectedin) for the treatment of Small Cell Lung Cancer (...

March 7, 2024 | Thursday | News
Taiwan-based Formosa Pharma receives US FDA approval for ophthalmic steroid

Taiwan-based Formosa Pharmaceuticals and AimMax Therapeutics (United States) have announced that the US Food and Drug A...

March 6, 2024 | Wednesday | News
Pharmarack, Informatica partners to revolutionize Healthcare Network of India

Informatica, an enterprise cloud data management solution provider, announced that Pharmarack, India’s larges...

March 5, 2024 | Tuesday | News
Merck injects € 20 M into new distribution centre in Brazil

Merck, a leading science and technology company, is opening a new € 20 million distribution centre in Cajamar...

March 4, 2024 | Monday | News
PHILMEDICAL EXPO 2024: Sets to Revolutionize Healthcare in the Philippines

The PhilMedical Expo 2024, alongside INDEC, PhilMedtech, and PhilDental Expo. From August 14th to 16th, 2024, at the re...

March 4, 2024 | Monday | News
Singapore MOH enrolls Pfizer's oral drug for atopic dermatitis (AD) under MAF listing

Singapore Ministry of Health (MOH) has listed Pfizer Singapore’s Atopic dermatitis (AD) oral tablet abrocitinib un...

March 1, 2024 | Friday | News
Can Shorter Regimens Eliminate Drug-Resistant Tuberculosis?

Despite countries making bold commitments to end TB by 2030, in the Sustainable Development Goals (SDGs), the WHO End TB...

March 1, 2024 | Friday | Analysis
February's Bold Pivot: Layoffs Ignite Strategic Renewal in Biotech & BioPharma Industry

In February, the Biotech and BioPharma industries faced a wave of strategic layoffs, signaling a significant shift towar...

February 28, 2024 | Wednesday | Analysis
Taiwan FDA approves Shionogi's FETROJA for treating complicated urinary tract infections

Japan headquartered pharmaceutical company Shionogi & Co. has received approval from the Taiwan Food and Drug Admini...

February 28, 2024 | Wednesday | News
Japan's Daiichi Sankyo invests €1B in Germany site, expanding into innovation centre

With investments of approximately one billion euros, Japan headquartered Daiichi Sankyo will expand its production and ...

February 29, 2024 | Thursday | News
Australian firm Telix Pharma expands US infrastructure with acquisition of IsoTherapeutics

Australia-based Telix Pharmaceuticals has entered into an agreement to acquire IsoTherapeutics Group, LLC, a specialty r...

February 27, 2024 | Tuesday | News